Episode 08.26.2026 - Top 20 Drugs of 2025: High Blood Pressure
SUMMARY
This week, The Dr. Ardis Show continues the Top 20 Drugs of 2025 series with a deep dive into the five high blood pressure medications that made the list: amlodipine (#2), lisinopril (#4), losartan (#6), metoprolol (#12), and hydrochlorothiazide (#20). Dr. Ardis opens with the Mayo Clinic's blood pressure categories and the difference between primary and secondary hypertension, then walks through each drug's published package-insert side effects, including amlodipine's edema and Parkinson's-like symptoms, lisinopril's black box pregnancy warning and liver injury risk, losartan's kidney failure and heart block reports, metoprolol's 27.5% heart failure and 1-in-10 death rate in trials, and hydrochlorothiazide's necrotizing vasculitis and toxic epidermal necrolysis.
He then covers the published research behind natural alternatives: guggul (Commiphora mukul) resin extract and Arjuna bark for cardiac function and cholesterol, vitamin C for systolic and diastolic blood pressure reduction, and magnesium as a natural calcium channel blocker that - unlike amlodipine - acts on both the L-type and T-type calcium channels in heart cells.
Nature Wins Products Featured
TAGS
The Dr. Ardis Show, Dr. Bryan Ardis, Top 20 Drugs, High Blood Pressure, Hypertension, Amlodipine, Lisinopril, Losartan, Metoprolol, Hydrochlorothiazide, Calcium Channel Blockers, ACE Inhibitors, Beta Blockers, Diuretics, Magnesium, Vitamin C, Guggul, Arjuna, Heart Health, Nature Wins Guggul Resin, Nature Wins Cardio-Flow, Nature Wins Immune-C, Nature Wins Magnesium Complex, Nature Wins Hydrate Complete